HEALTHLYNKED NEW (HLYKD) Stock Price, News & Analysis
Company Description
For FY2025, HEALTHLYNKED NEW reported revenue of $2.1M with net income of -$3.3M and diluted earnings per share of $-1.16. The company operates at a net profit margin of -158.8%.
This page collects what Stock Titan holds for HLYKD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HLYKD Rankings
Latest News
SEC Filings
HEALTHLYNKED NEW has filed 5 recent SEC filings, including 2 Form S-1/A, 1 Form 10-Q, 1 Form 10-K, 1 Form NT 10-Q. The most recent filing was submitted on May 29, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HLYKD SEC filings →
Financial Highlights
HEALTHLYNKED NEW generated $2.1M in revenue in FY2025, operating income reached -$2.1M (-102.3% operating margin), and net income was -$3.3M, reflecting a -158.8% net profit margin. Diluted earnings per share stood at $-1.16. The company generated -$1.7M in operating cash flow. With a current ratio of 0.22, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in HEALTHLYNKED NEW (HLYKD) currently stands at 2.4 thousand shares, up 674.7% from the previous reporting period, representing 0.1% of the shares outstanding. Since September 2025, short interest has increased by 674.7%.
Days to Cover History
Days to cover for HEALTHLYNKED NEW (HLYKD) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.